Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

NCT02931981 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-10-13

No results posted yet for this study

Summary

Our study aims to evaluate the role of Dickkopf-4 as biomarkers in the treatment of gastrointestinal stromal tumor.

Conditions

  • Gastrointestinal Stromal Tumor

Interventions

PROCEDURE

surgery or biopsy

Do radical surgery or biopsy to obtain a pathological result

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2016-10-31
Completion
2019-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02931981 on ClinicalTrials.gov